Current manufacturing processes across all industrial sectors rely on petrochemicals, either to power them, or as starting points for their product. This over reliance on finite fossil resources is having a detrimental impact on the health of the world and its population. Professor Aline Miller explains how industrial biotechnology can break this addiction to petrochemicals […]
Regulation of human embryo models is urgent
Human embryo models are created from stem cells and provide opportunities to study early embryo development in ways that would generally be impermissible if real human embryos were used. Here, Dr Jonathan Lewis and Professor Soren Holm argue that with human embryo models becoming more advanced, regulations governing human embryo research need to be established […]
Unjamming the (bio)printer: how can regulatory reform unleash new and advanced biomaterials?
3D bioprinting technologies hold huge potential to transform patient care and treatment, delivering the next generation of personalised medicine. But current legislative boundaries are poorly defined, and the pathways to approval are unclear, creating unnecessary delays and costs in getting these new technologies to patients. Here, Dr Marco Domingos from the Bioprinting Technology Platform argues […]
Planning ahead: A multi-sector approach to net zero
With climate change increasing some resources’ uncertainty – and global development making others scarcer and more interdependent – society requires improved planning and policy frameworks to deliver a secure, equitable and resilient transformation to net zero. In this article from our publication On Resilience, Professor Julien Harou, Dr Eduardo A. Martínez Ceseña and Professor Mathaios Panteli explore how […]
Capacity for change: improving the governance of dementia research
The Mental Capacity Act 2005 (MCA) outlines legal decision-making procedures in England and Wales for people above the age of 16 who have an impairment of, or disturbance in, the functioning of the mind or brain. It specifies that research involving these people must be approved by a research ethics committee (REC) sanctioned by the […]
Not immaterial: Why the UK must play to its strengths in quantum technology
The UK Science and Technology Framework has recently been announced by Prime Minister Rishi Sunak, with Quantum Technologies (QTs) identified as one of five critical technologies. But what is needed to realise this vision – and should the UK invest everywhere, or target its areas of expertise? Here, Professor Richard Curry outlines how the country […]
Graphene as a regional-global innovation model
A new national policy report has identified the graphene innovation ecosystem at Manchester as a regional hub for international partnership and investment. In this article, James Baker explores how this success demonstrates that research and development (R&D) investment into specialist regional clusters like Graphene@Manchester provides national government with an excellent return on investment as they […]
Global partnerships: How can international research collaborations boost our health and economy?
The University of Manchester is a founding partner of the Kenya-UK Healthcare Alliance, which aims to share best practice and reciprocal training between the two nations, particularly in the area of cancer care. In this article, from our On Cancer publication, Professor Keith Brennan, Dr F. George Njoroge, and Professor Rob Bristow outline how these […]
Fighting the war with drugs: How can psychedelic-assisted therapies help veterans?
Around 17% of recent military veterans in the UK report symptoms of post-traumatic stress disorder (PTSD) and currently available treatments don’t work for many of these. Here, Professor Jo Neill, Dr Verity Wainwright, and Frances Smith report the findings of a new study into the role that psilocybin (the active constituent of so-called ‘magic’ mushrooms) […]
Advancing cell and gene therapies: Levelling-up life sciences investment in the North-West
Life sciences – including new cancer treatments – forms a central pillar of the UK Government’s post-Brexit plan for science and technology. But how could this focus also play a role in another key tenet of British policymaking; the levelling-up agenda? In this blog, adapted from our On Cancer publication, Professor Fiona Thistlethwaite and Professor […]